Serum Biomarkers of Inflammation and Turnover of Joint Cartilage Can Help Differentiate Psoriatic Arthritis (PsA) Patients from Osteoarthritis (OA) Patients

Documenti analoghi

• The influence of tumour necrosis factor α inhibitors treatment – etanercept on serum concentration of biomarkers of inflammation and cartilage turnover in psoriatic arthritis patients
  di: Waszczykowski, Michał, et al.
  Pubblicazione: (2020)
• Interleukin-18, interleukin-20, and matrix metalloproteinases (MMP-1, MMP-3) as markers of psoriatic arthritis disease severity and their correlations with biomarkers of inflammation and turnover of joint cartilage
  di: Waszczykowski, Michał, et al.
  Pubblicazione: (2020)
• Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA
  di: Frasca, Loredana, et al.
  Pubblicazione: (2018)
• Patient-centered psoriatic arthritis (PsA) activity assessment by Stockerau Activity Score for Psoriatic Arthritis (SASPA)
  di: Leeb, Burkhard F, et al.
  Pubblicazione: (2015)
• Ultrasound assessment in psoriatic arthritis (PsA) and psoriasis vulgaris (non-PsA): which sites are most commonly involved and what features are more important in PsA?
  di: Tang, Yuanjiao, et al.
  Pubblicazione: (2020)